ZVSA
ZyVersa Therapeutics, Inc.Company with tickers: ZVSA
CIK
1859007
CUSIP
98987D300
Shares Outstanding
8,095,921
Price
$0.20
Market Cap
$1.62M
P/E Ratio
-0.02
EPS (Diluted)
$-8.48
52W High
$1.67
52W Low
$0.11
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $2,144,571 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $258,876 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-2,144,571 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-2,256,930 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.73 | USD/shares | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.73 | USD/shares | 2025-03-31 | 10-Q | 2026-05-13 |